Amicogen, Inc.
Research Amicogen, Inc. (092040.KQ) on Bullrun: market cap KRW 65.10B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker092040.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyKRW
- Market capKRW 65.10B
- Financial periodQ2 2026
- RevenueKRW 13.39B
- Net income-KRW 20.75B
- Free cash flowKRW 4.01B
- Gross margin21.7%
Valuation Snapshot
latest market cap is KRW 65.10B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 65.10B | n/a | n/a | n/a |
About Amicogen, Inc.
Amicogen, Inc. operates as an industrial biotechnology company in South Korea and internationally. The company develops, produces, and sells of enzymes and new materials; and produces food-related additives and health functional food. It manufactures and sells of biopharmaceutical materials and resins for purifying pharmaceutical proteins and health and beauty products.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Amicogen, Inc.'s market cap?
Amicogen, Inc.'s market capitalization is KRW 65.10B.
What does Amicogen, Inc. do?
Amicogen, Inc. operates as an industrial biotechnology company in South Korea and internationally. The company develops, produces, and sells of enzymes and new materials; and produces food-related additives and health functional food. It manufactures and sells of biopharmaceutical materials and resins for purifying pharmaceutical proteins and health and beauty products. In addition, the company offers oral incurable and rare disease treatments, as well as manufactures and sells of pharmaceutical raw materials, animal drugs, human drugs, etc.